Search Results

Combination therapy synergism prediction for virus treatment using machine learning models.

• Authors : Majidifar S; Department of Computer Science and Information Technology, Institute for Advanced Studies in Basic Sciences (IASBS), Zanjan, Iran.; Zabihian A

Subjects: Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/therapeutic use ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/pharmacology ; Machine Learning*

• Source: PloS one [PLoS One] 2024 Sep 04; Vol. 19 (9), pp. e0309733. Date of Electronic Publication: 2024 Sep 04 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

Successful combination therapy for recurrent refractory cytomegalovirus treatment in a kidney transplant recipient.

• Authors : Marvin JE; Department of Pharmacy, Yale New Haven Hospital, New Haven, Connecticut, USA.; Trubin PA

Subjects: Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/therapeutic use ; Cytomegalovirus*/Cytomegalovirus*/Cytomegalovirus*/drug effects ; Cytomegalovirus*/Cytomegalovirus*/Cytomegalovirus*/isolation & purification

• Source: Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2024 Aug; Vol. 26 (4), pp. e14329. Date of Electronic Publication: 2024 Jul Publisher: Munksgaard Country of Publication: Denmark NLM ID: 100883688 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Steroid-Dependency in Posner-Schlossman Syndrome: A Suggested Topical 2% Ganciclovir and Gradual Decrement of Topical Steroid Combination Therapy from Shanghai PSS Study.

• Authors : Ying Y; Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China.; NHC Key Laboratory of Myopia, Fudan University, Shanghai, China.

Subjects: Ganciclovir*/Ganciclovir*/Ganciclovir*/administration & dosage ; Glucocorticoids*/Glucocorticoids*/Glucocorticoids*/administration & dosage ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/administration & dosage

• Source: Ocular immunology and inflammation [Ocul Immunol Inflamm] 2024 Jul; Vol. 32 (5), pp. 513-519. Date of Electronic Publication: 2023 Sep 13.Publisher: Informa Healthcare Country of Publication: England NLM ID: 9312169 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Effectiveness and Safety of Glecaprevir/Pibrentasvir Combination Therapy in Patients Diagnosed with Chronic Hepatitis C.

• Authors : Karabulut, Kaan¹ ; Aygen, Bilgehan¹; Yıldız, Orhan¹

• Source: Journal of Clinical Practice & Research. May2025, Vol. 47 Issue 3, p309-315. 8p.

Record details

Chronic Hepatitis B Treatment Strategies Using Polymerase Inhibitor-Based Combination Therapy.

• Authors : Ohsaki E; Division of Virology, Department of Microbiology and Immunology, Osaka University Graduate School of Medicine, Suita 565-0871, Japan.; Suwanmanee Y

Subjects: Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use ; DNA-Directed DNA Polymerase/DNA-Directed DNA Polymerase/DNA-Directed DNA Polymerase/*metabolism ; Drug Therapy, Combination/Drug Therapy, Combination/Drug Therapy, Combination/*methods

• Source: Viruses [Viruses] 2021 Aug 26; Vol. 13 (9). Date of Electronic Publication: 2021 Aug 26.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915

Record details

Multiscale model of hepatitis C virus dynamics in plasma and liver following combination therapy.

• Authors : Woot de Trixhe X; Janssen R&D, Division of Janssen Pharmaceutica NV, Beerse, Belgium.; Krzyzanski W

Subjects: Models, Theoretical*; Antiviral Agents/Antiviral Agents/Antiviral Agents/*administration & dosage ; Hepacivirus/Hepacivirus/Hepacivirus/*isolation & purification

• Source: CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2021 Aug; Vol. 10 (8), pp. 826-838. Date of Electronic Publication: 2021 Jul 23.Publisher: Wiley Country of Publication: United States NLM ID: 101580011 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Effect of Aprotinin and Avifavir ® Combination Therapy for Moderate COVID-19 Patients.

• Authors : Ivashchenko AA; ChemRar High-Tech Center, 141401 Moscow, Russia.; Azarova VN

Subjects: COVID-19 Drug Treatment*; Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use ; Aprotinin/Aprotinin/Aprotinin/*therapeutic use

• Source: Viruses [Viruses] 2021 Jun 27; Vol. 13 (7). Date of Electronic Publication: 2021 Jun 27.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915

Record details

Viral burden, inflammatory milieu and CD8 + T-cell responses to influenza virus in a second-generation thiazolide (RM-5061) and oseltamivir combination therapy study.

• Authors : Nüssing S; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, Victoria, Australia.; Mifsud E

Subjects: Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use ; Orthomyxoviridae Infections/Orthomyxoviridae Infections/Orthomyxoviridae Infections/*drug therapy ; Oseltamivir/Oseltamivir/Oseltamivir/*therapeutic use

• Source: Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2020 Nov; Vol. 14 (6), pp. 678-687. Date of Electronic Publication: 2020 Jun 25.Publisher: Wiley Country of Publication: England NLM ID: 101304007 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1750-2659

Record details

REVIEW - Advancements in combination therapy of Hepatitis C virus.

• Authors : Jahangeer M; Department of Biochemistry, Government College University Faisalabad, Faisalabad, Pakistan.; Ud Din NZ

Subjects: Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use ; Hepacivirus/Hepacivirus/Hepacivirus/*drug effects ; Hepatitis C, Chronic/Hepatitis C, Chronic/Hepatitis C, Chronic/*drug therapy

• Source: Pakistan journal of pharmaceutical sciences [Pak J Pharm Sci] 2020 Sep; Vol. 33 (5), pp. 2171-2178.Publisher: Faculty of Pharmacy, University of Karachi Country of Publication: Pakistan NLM ID: 9426356 Publication Model: Print Cited Medium: Internet

Record details

Triple combination therapy of favipiravir plus two monoclonal antibodies eradicates influenza virus from nude mice.

• Authors : Kiso M; Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.; Yamayoshi S

Subjects: Amides/Amides/Amides/*administration & dosage ; Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/*administration & dosage ; Antiviral Agents/Antiviral Agents/Antiviral Agents/*administration & dosage

• Source: Communications biology [Commun Biol] 2020 May 07; Vol. 3 (1), pp. 219. Date of Electronic Publication: 2020 May 07.Publisher: Nature Publishing Group UK Country of Publication: England NLM ID: 101719179 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details